Health

This drug improves survival in sickest COVID-19 patients: Study

This drug improves survival in sickest COVID-19 patients: Study

A drug normally used in rheumatoid arthritis and cancer treatments -- tocilizumab -- improves hospital survival in critically ill Covid-19 patients admitted to the intensive care unit (ICU), say researchers. The study, published in the journal The Lancet Rheumatology, included 630 patients who were admitted to the ICUs of 13 Hackensack Meridian Health hospitals in New Jersey.

Click here to read more -->
×